Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
SMAD4 maintains the fluid shear stress set point to protect against arterial-venous malformations
Kuheli Banerjee, … , Martin A. Schwartz, Roxana Ola
Kuheli Banerjee, … , Martin A. Schwartz, Roxana Ola
Published July 25, 2023
Citation Information: J Clin Invest. 2023;133(18):e168352. https://doi.org/10.1172/JCI168352.
View: Text | PDF
Research Article Vascular biology

SMAD4 maintains the fluid shear stress set point to protect against arterial-venous malformations

  • Text
  • PDF
Abstract

Vascular networks form, remodel, and mature under the influence of both fluid shear stress (FSS) and soluble factors. Physiological FSS promotes and maintains vascular stability via synergy with bone morphogenic proteins 9 and 10 (BMP9 and BMP10). Conversely, mutation of the BMP receptors activin-like kinase 1 (ALK1), endoglin (ENG), or the downstream effector, SMAD family member 4 (SMAD4) leads to hereditary hemorrhagic telangiectasia (HHT), characterized by fragile and leaky arterial-venous malformations (AVMs). How endothelial cells (ECs) integrate FSS and BMP signals in vascular development and homeostasis and how mutations give rise to vascular malformations is not well understood. Here, we aimed to elucidate the mechanism of synergy between FSS and SMAD signaling in vascular stability and how disruption of this synergy leads to AVMs. We found that loss of Smad4 increased the sensitivity of ECs to flow by lowering the FSS set point, with resulting AVMs exhibiting features of excessive flow-mediated morphological responses. Mechanistically, loss of SMAD4 disinhibits flow-mediated KLF4-TIE2-PI3K/Akt signaling, leading to cell cycle progression–mediated loss of arterial identity due to KLF4-mediated repression of cyclin dependent Kinase (CDK) inhibitors CDKN2A and CDKN2B. Thus, AVMs caused by Smad4 deletion are characterized by chronic high flow remodeling with excessive EC proliferation and loss of arterial identity as triggering events.

Authors

Kuheli Banerjee, Yanzhu Lin, Johannes Gahn, Julio Cordero, Purnima Gupta, Islam Mohamed, Mariona Graupera, Gergana Dobreva, Martin A. Schwartz, Roxana Ola

×

Figure 4

KLF4 mediates the shear stress–induced aberrant EC events within AVMs.

Options: View larger image (or click on image) Download as PowerPoint
KLF4 mediates the shear stress–induced aberrant EC events within AVMs.
(...
(A–C) Representative confocal images of P6 Tx induced fl/fl, Smad4iΔEC, Klf4iΔEC, and Smad4;Klf4iΔEC retinal plexus labeled for ERG (nuclei-white), GOLPH4 (golgi-red), and IB4 (green) (A) and ERG, GOLPH4, and IB4 (green line) (B). Yellow arrowheads indicate the orientation of ECs within the AVM against the flow direction from vein toward the artery. (C) Panels illustrating EC polarization based on position of golgi in relation to the nucleus in the direction of migration (green arrows). (D) Quantification of EC polarization: against, with flow, and neutral (nonpolarized) in capillaries from P6 Tx-induced retinas from the indicated genotypes (n = 3 retinas/group). (E) Upper panel: confocal images of P6 Tx-induced fl/fl, Smad4iΔEC, Klf4iΔEC, and Smad4;Klf4iΔEC retinal plexus labeled for PECAM (white) and ERG (green). Lower panel: magnified pictures (red insets in upper panels) labeled for PECAM (white). Small red arrowheads indicate loss of PECAM at cell-cell junctions in Klf4iΔEC retinas. (F and G) Quantification of length/width ratio (F) and of cell area (G) in capillary ECs in the indicated genotypes (n = 6 [2 images (average of 50–100 cells/image) per retina]/group). (H) Representative labeling for EdU (white) and ERG (green) in vascular plexus of retinas from P6 fl/fl, Smad4iΔEC, Klf4iΔEC, and Smad4;Klf4iΔEC mice. Blue arrowheads in E and H indicate AVMs. (I) S-phase ratio (EdU+/ERG+) per total amount of ECs (ERG+) in the vascular plexus of the indicated genotypes (%) (n = 12 images from 4 retinas/group). Scale Bars: 50μm in A–C, E (upper panel) and H; 20μm in magnified images (lower panel) from E. 1-way Anova (D, F, G, and I) was used to determine statistical significance. Data are represented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001. a, artery; v, vein.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts